US Map / Arizona
State AZ

Clinical Trials in Arizona

Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 242 actively recruiting studies with Arizona sites out of 242 registered in total. The busiest research areas in Arizona are Solid Tumor, Prostate Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Arizona, AstraZeneca. By stage, Arizona trials break down as Phase 1 (37), Phase 2 (77), Phase 3 (80), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
242
Recruiting Now
242
← Back to US Map
Top Conditions in Arizona
Solid Tumor (6)Prostate Cancer (6)Obesity (6)Colorectal Cancer (4)Multiple Myeloma (3)Cancer (3)Advanced Solid Tumor (3)Developmental Language Disorder (3)Overweight (3)Colorectal Neoplasms (3)Carcinoma, Non-Small-Cell Lung (3)Graves' Disease (3)

Frequently Asked Questions — Clinical Trials in Arizona

How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 242 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 242. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Prostate Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arizona

NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT04062565 Phase 3
Recruiting
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vasc...
Condition
Pulmonary Arterial Hypertension
Enrollment
20 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT00477100 N/A
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Ti...
Condition
Inflammatory Breast Carcinoma
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
View Trial →
NCT07228845 N/A
Recruiting
Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Indiv...
Condition
Hearing Aids
Enrollment
32 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT06729775 N/A
Recruiting
Disentangling the Role of Culture, Life Stage, and Information Design to Facilit...
Condition
Education, Health
Enrollment
1,546 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT04567771 N/A
Recruiting
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for ...
Condition
Cervical Carcinoma
Enrollment
121 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07554521 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Lo...
Condition
Advanced Unresectable Gastric Adenocarcinoma
Enrollment
30 pts
Location
United States
Sponsor
BeOne Medicines
View Trial →
NCT06556693 N/A
Recruiting
Janus II Feasibility
Condition
Sleep Apnea
Enrollment
40 pts
Location
United States
Sponsor
Zoll Medical Corporation
View Trial →
NCT05882058 Phase 2
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With...
Condition
Small Cell Lung Carcinoma
Enrollment
204 pts
Location
United States, Belgium, Bulgaria
Sponsor
Boehringer Ingelheim
View Trial →
NCT06379789 Phase 1, Phase 2
Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX G...
Condition
Hemophilia B
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07358078 N/A
Recruiting
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients ...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
2,000 pts
Location
United States, Germany, Japan
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT05732103 Phase 1, Phase 2
Recruiting
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk...
Condition
Acute Myeloid Leukemia
Enrollment
225 pts
Location
United States
Sponsor
Chordia Therapeutics, Inc.
View Trial →
NCT07216027 Phase 2
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Condition
Atopic Dermatitis
Enrollment
165 pts
Location
United States, Bulgaria, Canada
Sponsor
Pfizer
View Trial →
NCT07933822 N/A
Recruiting
Therapy for Adverbial Clauses
Condition
Developmental Language Disorder
Enrollment
16 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT07817251 Phase 3
Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semagl...
Condition
Diabetes Mellitus, Type 2
Enrollment
210 pts
Location
United States
Sponsor
Novo Nordisk A/S
View Trial →
NCT07369154 Phase 3
Recruiting
52-week Open Label Safety-Tolerability Study
Condition
Schizophrenia
Enrollment
900 pts
Location
United States
Sponsor
LB Pharmaceuticals Inc.
View Trial →
NCT06631209 N/A
Recruiting
Effectiveness of Transcranial Magnetic Stimulation of the Default Mode Network t...
Condition
Insomnia
Enrollment
144 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT06767514 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
View Trial →
NCT07397338 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Sol...
Condition
Advanced Solid Tumors
Enrollment
370 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
View Trial →
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07770828 Phase 3
Recruiting
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic...
Condition
Dry Age-related Macular Degeneration
Enrollment
237 pts
Location
United States
Sponsor
Ocugen
View Trial →
Page 2 of 10 — 242 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology